收藏切换
Exploring the progress of imatinib nano-formulations in mediating gastrointestinal stromal tumor development through the immune microenvironment
收藏切换
Xinxuan MA1, Jian CHEN2, *
World Clinical Drug | 2025, 46(10) : 1066 - 1071
Less
收藏切换
World Clinical Drug | 2025, 46(10): 1066-1071
• Review •
Exploring the progress of imatinib nano-formulations in mediating gastrointestinal stromal tumor development through the immune microenvironment
Full
Xinxuan MA1, Jian CHEN2, *
Affiliations
  • 1.College of Clinical Medicine, Shandong Second Medical University, Weifang 261042, Shandong Province, China
  • 2.Department of Oncology, Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China
Published: 2025-10-10 doi: 10.13683/j.wph.2025.10.013
Outline
收藏切换

Gastrointestinal stromal tumor is a common mesenchymal tumor in the gastrointestinal tract, mainly occurring in the elderly population. Imatinib, as a treatment for gastrointestinal stromal tumor of the first-line drugs, has remarkable efficacy, but its easy to be nuclease degradation in the body, leading to low bioavailability. Clinically, large doses of the drug are often required, which can lead to serious adverse reactions such as neutropenia, coagulation dysfunction and hepatotoxicity. Imatinib nanoparticles can effectively stimulate the activation of immune cells, reduce the infiltration of immunosuppressive cells, and reshape the immune microenvironment by regulating the tyrosine kinase receptor protein-related signaling pathways, thereby enhancing the anti-tumor immune effect. In addition, targeted drug nanoparticles can prolong the action time of imatinib in the body, providing the possibility of reducing the drug dosage.This article reviewed the relevant research on imatinib nanoformulations in recent years, aiming to provide scientific basis and theoretical support for the treatment of gastrointestinal stromal tumors with new soft drug nanoparticles modified by hyaluronic acid, and to offer references for the application of new clinical drugs in the future.

gastrointestinal stromal tumor  /  imatinib  /  nanomedicine  /  hyaluronic acid
马歆璇, 陈剑. 探索伊马替尼纳米制剂通过免疫微环境介导胃间质瘤发展的研究进展. 世界临床药物, 2025 , 46 (10) : 1066 -1071 . DOI: 10.13683/j.wph.2025.10.013
Xinxuan MA, Jian CHEN. Exploring the progress of imatinib nano-formulations in mediating gastrointestinal stromal tumor development through the immune microenvironment[J]. World Clinical Drug, 2025 , 46 (10) : 1066 -1071 . DOI: 10.13683/j.wph.2025.10.013
Year 2025 volume 46 Issue 10
49
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.10.013
  • Receive Date:2025-03-25
  • Online Date:2026-11-09
  • Published:2025-10-10
Article Data
Affiliations
History
  • Received:2025-03-25
Affiliations
    1.College of Clinical Medicine, Shandong Second Medical University, Weifang 261042, Shandong Province, China
    2.Department of Oncology, Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.10.013
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT